Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease

Summary

The investigators will see if the drug teriflunomide (which is in use in other immune disorder (multiple sclerosis)) can inhibit the immune activation in celiac disease patients during a 3 day gluten challenge. This will be measured in a blood sample.

Timeline

Start

2021-04-16

Primary completion

2022-10-15

Completion

2023-12-31

Drugs

Indications